View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
BeEAM - Bendamustine 100 / Etoposide 200 / Cytarabine 200 / Melphalan 140, prior to autologous Stem Cell Transplantation
Protocol-ID: 879 V1.0 (Mini), BeEAM (BEND100/CYTA200/ETOP200/MELP140), before ASCT, NHL/HLIndication(s)
- Hodgkin Lymphoma; ICD-10 C81.-
- Mantle Cell Lymphoma; ICD-10 C83.1
- NHL, B-Cell Type, Anaplastic Large Cell Lymphoma, ALK-Positive; ICD-10 C84.6
- NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
- NHL, B-Cell Type, Follicular grade IIIb; ICD-10 C82.-, C82.7, C82.9
Links
- A Phase 2 Study from Spanish Geltamo Group Investigating the Efficacy and Safety of Bendamustine As Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients with Aggressive Lymphomas: Second Interim Analysis [URL]
- Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin´s Lymphoma [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 28.02.2017